The genetic advantage
There have been significant investments at an ever-increasing rate – both in academia and industry – to develop new therapies in therapeutic areas and scientific approaches. In 2019, the US pharmaceutical industry invested $83 billion in research and development, about 10 times the amount invested in the entire 1980s (adjusted for inflation) (1). Yet the …